Search Count: 23
 |
Structure Of The Sars-Cov-2 Main Protease In Complex With Inhibitor Sr-B-78
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2026-03-04 Classification: VIRAL PROTEIN Ligands: A1CG8 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-03-04
Ligands: A1CG8
 |
Structure Of The Sars-Cov-2 Main Protease In Complex With Inhibitor Mpi60
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-08-30 Classification: VIRAL PROTEIN Ligands: WGE |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-08-30
Ligands: WGE
 |
Structure Of The Sars-Cov-2 Main Protease In Complex With Inhibitor Mpi37
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2023-08-30 Classification: VIRAL PROTEIN, Hydrolase Ligands: WGI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-08-30
Ligands: WGI
 |
Crystal Structure Of Hla-B*15:01 In Complex With Spike Derived Peptide Nqklianaf From Oc43 Virus
Organism: Homo sapiens, Human coronavirus 229e
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2023-06-14 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: ACT |
Organism: Homo sapiens, Human coronavirus 229e
Method: X-RAY DIFFRACTION
Release Date: 2023-06-14
Ligands: ACT
 |
Crystal Structure Of Hla-B*15:01 In Complex With Spike Derived Peptide Nqklianqf From Sars-Cov-2 Virus
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2023-06-14 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: ACT, PEG |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-14
Ligands: ACT, PEG
 |
Structure Of The Sars-Cov-2 Main Protease In Complex With Inhibitor Mpi87
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2023-04-12 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: 9GI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-04-12
Ligands: 9GI
 |
Structure Of The Sars-Cov-2 Main Protease In Complex With Inhibitor Mpi48
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-11-09 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: 8T6 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-11-09
Ligands: 8T6
 |
Structure Of The Sars-Cov-2 Main Protease In Complex With Inhibitor Mpi49
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-11-09 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: 8UI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-11-09
Ligands: 8UI
 |
Structure Of The Sars-Cov-2 Main Protease In Complex With Inhibitor Mi-09
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-11-09 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: I80 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-11-09
Ligands: I80
 |
Griffithsin Mutant Y28W
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2022-05-25 Classification: SUGAR BINDING PROTEIN Ligands: MAN |
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION
Release Date: 2022-05-25
Ligands: MAN
 |
Griffithsin Variant Y28A/Y68A/Y110A
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2022-05-18 Classification: SUGAR BINDING PROTEIN Ligands: MAN, SO4 |
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION
Release Date: 2022-05-18
Ligands: MAN, SO4
 |
Griffithsin Mutant Y28F/Y68F/Y110F
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2022-05-18 Classification: SUGAR BINDING PROTEIN Ligands: MAN, SO4 |
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION
Release Date: 2022-05-18
Ligands: MAN, SO4
 |
Griffithsin Variant Y28W/Y68W/Y110W
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2022-05-18 Classification: SUGAR BINDING PROTEIN |
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION
Release Date: 2022-05-18
 |
Griffithsin Variant Y28A
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2022-05-18 Classification: SUGAR BINDING PROTEIN |
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION
Release Date: 2022-05-18
 |
Griffithsin-S10Y/S42Y/S88Y
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2022-05-18 Classification: SUGAR BINDING PROTEIN Ligands: MAN |
Organism: Griffithsia sp. (strain q66d336)
Method: X-RAY DIFFRACTION
Release Date: 2022-05-18
Ligands: MAN
 |
Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With A Pyrrolo[2,3-D]Pyrimidine Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.51 Å Release Date: 2022-01-19 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: CL, 7QU |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-01-19
Ligands: CL, 7QU
 |
Co-Crystal Structure Of Perk With Inhibitor (R)-2-Amino-N-Cyclopropyl-5-(4-(2-(3,5-Difluorophenyl)-2-Hydroxyacetamido)-2-Methylphenyl)Nicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.81 Å Release Date: 2021-05-19 Classification: TRANSFERASE Ligands: Z6P |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-05-19
Ligands: Z6P
 |
Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With A Pyrazolo[1,5-A]Pyrimidine Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2020-02-26 Classification: Transferase/Transferase Inhibitor Ligands: QX1, SO4, CL, ACT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-02-26
Ligands: QX1, SO4, CL, ACT
 |
Egfr Kinase Domain In Complex With A Covalent Aminobenzimidazole Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2016-07-27 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5X4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-07-27
Ligands: 5X4
 |
Egfr Kinase Domain T790M Mutant In Complex With A Covalent Aminobenzimidazole Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2016-07-27 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5X4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-07-27
Ligands: 5X4